The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (4), 389-407
- https://doi.org/10.1016/0305-7372(90)90081-p
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- A study of human small‐cell lung carcinoma (hsclc) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (cddp) resistanceInternational Journal of Cancer, 1990
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsEuropean Journal of Cancer and Clinical Oncology, 1989
- Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell lineEuropean Journal of Cancer and Clinical Oncology, 1989
- Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionChemico-Biological Interactions, 1988
- Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximineThe British Journal of Radiology, 1987
- Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of actionBiochemistry, 1987
- Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexesChemico-Biological Interactions, 1987
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986
- Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothioneinToxicology and Applied Pharmacology, 1981